Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study)

Clinics and Research in Hepatology and Gastroenterology

Volumn 40, Issue 3, 2016, Pages 340-348

  Abergel, Armand ^a,e   Rotily, Michel ^b   Branchoux, Sébastien ^c   Akremi, Raoudha ^c   de Léotoing, Lucie ^d   Vainchtock, Alexandre ^d   Gaudin, Anne Françoise ^c  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b CENTRE HOSPITALIER DU PAYS D AIX   (France)

^c BRISTOL MYERS SQUIBB   (United States)

^d HEVA   (France)

^e UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC HEPATITIS C; COST OF ILLNESS; DECOMPENSATED LIVER CIRRHOSIS; DISEASE SEVERITY; FEMALE; FRANCE; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; INFANT; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; NEWBORN; PERSISTENT VIRUS INFECTION; RETROSPECTIVE STUDY; ECONOMICS; HOSPITAL MORTALITY; LIVER CIRRHOSIS; LIVER TUMOR; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FRANCE; HEPATITIS C, CHRONIC; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84953248476     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2015.08.006     Document Type: Article

References (20)

1. Te H.S., Jensen D.M. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010, 14(1):1-21.
2. Meffre C. Prévalence des hépatites B et C en France en 2004 2006, Institut national de veille sanitaire, Saint-Maurice.
3. Delarocque-Astagneau E., Meffre C., Dubois F., Pioche C., Le Strat Y., Roudot-Thoraval F., et al. The impact of the prevention programme of hepatitis C over more than a decade: the French experience. J Viral Hepat 2010, 17(6):435-443.
4. Leleu H., Razavi H., Estes C., Calles B., Blachier M., Bonnard P., et al. Modeling the epidemiological impact of upcoming direct antiviral agents in hepatitis C treatment. Hepatology 2013, 58(Suppl. 1):748A.
5. Dhumeaux D. Prise en charge des personnes infectées par les virus de l'hépatite B ou de l'hépatite C 2014, Ministères des Affaires Sociales et de la Santé, Paris.
6. World Health Organization Estimates of numbers of deaths by sex, cause and WHO Region for 2002 2004, WHO, Geneva.
7. Marcellin P., Pequignot F., Delarocque-Astagneau E., Zarski J.P., Ganne N., Hillon P., et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol 2008, 48(2):200-207.
8. Muhlberger N., Schwarzer R., Lettmeier B., Sroczynski G., Zeuzem S., Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 2009, 9:34.
9. Burra P. Hepatitis C. Semin Liver Dis 2009, 29(1):53-65.
10. Lauer G.M., Walker B.D. Hepatitis C virus infection. N Engl J Med 2001, 345(1):41-52.
11. Agence de la biomédecine Le rapport médical et scientifique du prélèvement et de la greffe en France 2013, ABM, St Denis, France.
12. Deuffic-Burban S., Schwarzinger M., Obach D., Mallet V., Pol S., Pageaux G.P., et al. Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141). J Hepatol 2014, 61(1):7-14.
13. Rotily M., Vainchtock A., Jouaneton B., Wartelle-Bladou C., Abergel A. How did chronic hepatitis C impact costs related to hospital health care in France in 2009?. Clin Res Hepatol Gastroenterol 2013, 37(4):365-372.
14. Feeney E.R., Chung R.T. Antiviral treatment of hepatitis C. BMJ 2014, 348:g3308.
15. Septfons A., Gautier A., Brouard C., Bernillon P., Nicolau J., Larsen C. Prévalence, morbidité et mortalité associées aux hépatites B et C chroniques dans la population hospitalisée en France, 2004-2011. Bull Epidémiol Hebd 2014, 12:202-209.
16. World Health Organization International Classification of Diseases, 10th Revision 2010, WHO, Geneva. 4th Edition.
17. Ministère des Affaires Sociales et de la Santé Guide méthodologique de production des informations relatives à l'activité médicale et à sa facturation en médecine, chirurgie, obstétrique et odontologie 2014, [BO 2014/6 bis-Fascicule spécial-Juillet 2014].
18. Schwarzinger M., Thiébaut S., Mallet V., Rehm J. The confounding role of severe comorbidities and alcohol use disorders on prognosis in chronic hepatitis C virus infection: an analysis of the 2008-2012 French national hospital discharge database. J Hepatol 2015, 62(Suppl. 2):S237.
19. Pioche C., Brouard C., Pillonel J., Septfons A., Le Vu S., Jauffret-Roustide M., et al. Indicateurs régionaux de dépistage et de prévalence des hépatites B et C. France 2010-2012 2014, Institut de veille sanitaire, Saint-Maurice.
20. Deuffic-Burban S., Deltenre P., Louvet A., Canva V., Dharancy S., Hollebecque A., et al. Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France. J Hepatol 2008, 49(2):175-183.